Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs) after infection or vaccination. ASCs (plasmablasts) have been extensively studied in humans, but less is known about B cells that become activated but do not differentiate into plasmablasts. Here we have defined the phenotype and transcriptional program of a subset of antigen-specific B cells, which we have called 'activated B cells' (ABCs), that were distinct from ASCs and were committed to the MBC lineage. We detected ABCs in humans after infection with Ebola virus or influenza virus and also after vaccination. By simultaneously analyzing antigen-specific ASCs and ABCs in human blood after vaccination against influenza virus, we investigated the clonal overlap and extent of somatic hypermutation (SHM) in the ASC (effector) and ABC (memory) lineages. Longitudinal tracking of vaccination-induced hemagglutinin (HA)-specific clones revealed no overall increase in SHM over time, which suggested that repeated annual immunization might have limitations in enhancing the quality of influenza-virus-specific antibody.
Antigen-specific B cells proliferate and differentiate into ASCs or maintain the B cell program and become memory cells after infection or vaccination 1, 2 . The fate of responding B cells is tightly controlled by the expression of a network of transcription factors: Blimp-1, IRF4 and XBP-1 drive the differentiation of B cells into ASCs and induce expression of the molecular machinery required for antibody secretion, whereas Pax5, IRF8 and Bcl-6 are among a set of transcription factors that help B cells maintain their identity 3 .
A transient burst of antigen-specific ASCs can be detected in the peripheral blood of humans shortly after vaccination against influenza virus and after infection with influenza virus or dengue virus [4] [5] [6] . Defining the phenotype of the ASC subset paved the way for investigation of the repertoire of B cell responses in humans. ASCs have also been used for the rapid generation of human monoclonal antibodies that can be used as therapeutics and for diagnostics [6] [7] [8] . In the past few years, the dynamics, magnitude and specificity of the ASC response in the peripheral blood of humans after a variety of vaccinations and infections have been extensively studied 9 .
In addition to ASCs, antigen-specific human MBCs can also be detected in the peripheral blood 6, 10, 11 . These memory cells are usually identified either by culture of peripheral blood mononuclear cells (PBMCs) under various conditions to drive their differentiation into ASCs or through the use of fluorescence-labeled antigens. In this study, we defined a subset of antigen-specific B cells that were phenotypically, transcriptionally and functionally distinct from ASCs, which we have called ABCs. We detected ABCs in the peripheral blood of humans after infection with influenza virus or Ebola virus and after immunization against influenza virus. Sequencing of rearrangements in the locus encoding the immunoglobulin heavy chain (IGH) showed that clones that had members in HA-specific ABCs isolated at day 7 or 14 after immunization against influenza virus were detected at a higher frequency in the MBC compartment 3 months after vaccination than in samples obtained before vaccination. The magnitude and duration of the ABC response was substantially larger than that of the ASC response when assessed over the course of the infection or vaccination, which indicated that ABCs might be a particularly useful population to include for comprehensive analysis of the repertoire of vaccine-induced antigen-specific B cells.
RESULTS

Defining B cell subsets after immunization against influenza virus
The number of antigen-specific ASCs peaks in the peripheral blood of humans around day 7 after immunization against influenza virus 6 . We sought to investigate whether any other subset of antigen-specific B cells distinct from ASCs could be detected in the blood after vaccination. We hypothesized that as with ASCs, all recently antigen-engaged B cells would be actively proliferating. We used CD71 as a surface marker to label proliferating peripheral blood B cells in humans after immunization with the inactivated trivalent vaccine against seasonal influenza virus ('trivalent influenza vaccine' (TIV)). Among the isotype-switched, proliferating B cells, defined as CD3 − CD14 − CD16 − CD19 + IgD − CD71 hi cells isolated 7 d after vaccination, we identified two subsets: CD38 hi CD20 − (ASCs) and CD38 int-lo CD20 hi (ABCs) (Fig. 1a) . Both populations were (unlike naive (IgD + CD27 − ) B cells) positive for the intracellular proliferation marker Ki67 (Fig. 1b) , which confirmed that the cells were dividing.
We verified the identity and specificity of the ASC subset by ELISPOT without further culture (directly ex vivo) ( Fig. 1c and Supplementary Fig. 1a ). The majority (~82%) of IgG + ASCs were antigen specific (Fig. 1c) . However, ABCs did not spontaneously secrete antibodies under the same conditions (Fig. 1c) . ABCs differentiated into immunoglobulin G (IgG)-secreting cells when cultured in the presence of autologous CD19 − cells as feeders ( Fig. 1d and  Supplementary Fig. 1b) . Approximately 45% of the IgG + ABCs were specific to the vaccine against influenza virus (Fig. 1d) .
Like ASCs, ABCs were larger than naive B cells (Fig. 1e) . In contrast to ASCs, ABCs did not downregulate the expression of the signaltransduction receptor CD19 relative to that of naive B cells (Fig. 1e) . ABCs had higher expression of the costimulatory receptor CD27 and lower expression of the complement receptor CD21 than that of naive B cells (Fig. 1e) .
Downregulation of expression of the B cell transcription factor Pax5 is one of the earliest events of ASC differentiation [12] [13] [14] . Pax5 expression was significantly lower in ASCs than in naive B cells or ABCs, as measured by intracellular staining and flow cytometry (Fig. 1f) . In contrast, IRF4 expression was highest in ASCs relative to that in naive B cells and ABCs (Fig. 1g) . IRF8 is a transcription factor that antagonizes plasma cell differentiation 15 . Similar to Pax5 expression, IRF8 expression was significantly lower in ASCs than in naive B cells or ABCs (Fig. 1h) . These data demonstrated that following vaccination against influenza virus, two functionally and phenotypically distinct antigen-specific B cell subsets were detected in the peripheral blood of humans.
Detection of ABCs during infection with influenza or Ebola virus
After characterizing ABCs following vaccination against influenza virus, we sought to define this population during infection with influenza virus. We examined cryopreserved PBMCs from two patients with confirmed infection with the 2009 pandemic H1N1 influenza virus 16 . Blood was first collected on the day of enrollment (Day 0) and then at several time points thereafter (on or about days 4, 7, 11 and 27 after enrollment). At days 4 and 11 after enrollment, ASCs (CD20 − CD71 + ) and ABCs (CD20 hi CD71 + ) were distinguished among isotype-switched B cells (Fig. 2a) .
B cell responses to influenza virus in adults are dominated by recall responses 6, 17 . We sought to determine whether we could detect ABCs and ASCs in blood during the course of a primary immune response in humans. We had the unique opportunity to assess the immune responses in four patients (EVD02, EVD05, EVD09 and EVD15) infected with Ebola virus 18, 19 . The four patients were cared for in the Serious Communicable Diseases Unit at Emory University Hospital 18, 19 . Among CD19 + cells, we were able to clearly distinguish both ASCs (CD20 − CD71 hi ) and ABCs (CD20 hi CD71 + ) during the early phase of the infection (Fig. 2b) . A massive B cell response was observed in all patients approximately 2-3 weeks after the onset of symptoms, with ABCs and ASCs composing almost half of the peripheral blood B cells in three of the four patients (Fig. 2b) r e s o u r c e npg r e s o u r c e for EVD09, and 16.2% and 4.1% for EVD15, respectively (Fig. 2b) .
As the infection progressed, the frequency of B cells with the ABC phenotype increased, while the frequency of those with the ASC phenotype decreased (Fig. 2c) . These data demonstrated that ABCs were detected in the peripheral blood of humans shortly after viral infection, including after primary infection. They also suggested that ABCs were able to originate from MBCs (influenza virus) or naive B cells (Ebola virus).
Transcriptional distinction of ABCs versus ASCs and MBCs
To define the transcriptional program of ABCs, we analyzed the geneexpression profile of ABCs and compared it with those of ASCs, naive B cells and resting MBCs. We isolated these B cell populations by flow cytometry from four subjects 7 d after immunization with the 2013-2014 TIV (Supplementary Fig. 2 ). Unsupervised hierarchical clustering showed that both proliferating B cell subsets (ABCs and ASCs) grouped differently from the resting subsets (naive cells and MBCs) (Fig. 3a) . Notably, the four ABC samples formed a distinct cluster (Fig. 3a) , which indicated that the differences between ABCs and all other B cell subsets in their gene expression were sufficiently robust to be reproducible in the four subjects. Expression analysis revealed 192 genes that were upregulated in the ABC subset relative to their expression in at least two of the other three subsets ( Fig. 3b and Supplementary Table 1) . A substantial number of these genes encode proteins involved in antigen presentation (for example, HLA-DRA, HLA-DMA, HLA-DPA1, NCF2, CD1C and CTSH) or in signaling via the B cell antigen receptor (BCR) (CD19, RFTN1, CSK and PRKCB) ( Fig. 3b and Supplementary Table 1 ). To confirm the array results, we assessed the expression of some of these differentially expressed genes at the protein level (Fig. 3c) . Consistent with the array results, surface expression of the B cell-specific surface antigen CD20, the Toll-like receptor TLR10 and the lymphocyte surface marker CD52 was highest on ABCs (Fig. 3c) . Conversely, there were 760 genes upregulated in ASCs relative to their expression in at least two of the other three subsets (Fig. 3b) . These genes included PRDM1, IRF4 and XBP1, which encode key transcription factors that control the generation, maintenance and antibody secretion of ASCs (Fig. 3b) . Genes encoding proteins involved in extracellular protein synthesis and secretion (TRAM1, SEC61B and KDELR1) were also substantially upregulated in ASCs relative to their expression in at least two of the other three subsets (Fig. 3b) .
To better understand the interactions among the differentially expressed genes noted above and to put them into biological context, we performed gene-set-enrichment analysis of pre-ranked gene lists using published blood transcription modules as gene sets 20, 21 . This analysis confirmed that the genes expressed differentially in ABCs encoded products associated mainly with antigen processing and presentation and BCR signaling (Fig. 3d,e) . The genes expressed differentially in ASCs encoded products associated with a plasma cell signature and the molecular machinery essential for antibody secretion (Fig. 3d) . We next assessed the genes expressed differentially in ABC subsets relative to their expression in resting MBC subsets. We found that these genes encoded products associated mainly with cell-cycle regulation, antigen presentation, BCR signaling and YWHAH  PTTG1  ANAPC11  RBX1  ANAPC1  CDKN2D  CDC16  TFDP1  YWHAZ  TGFB1  YWHAB  CCND2   TNF  HLA-DRA  IFI30  HLA-DMA  HLA-E  HLA-DQA1  HLA-DPA1  HSPA4  B2M  CALR  PPP3CB  BTK  NFATC3  PRKCB  JUN  RAC2  RAC1  MAPK3  CD19  TNF  PPP3CB  PRKACB  RASGRP1  TGFB1  NFATC3  PRKCB  JUN  RASA1  RAC2  RAC1  MAPK3  CACNA1E  ELK1  FGF17  FLNA  MAP3K8 (Fig. 3f) . These data demonstrated that the ABCs represented a subset transcriptionally distinct from ASCs and resting MBCs. (Fig. 4) . The lower binding intensity for HA observed on HA-positive ASCs than on HA-positive ABCs was probably a result of the lower density of surface BCR expression on ASCs than on ABCs (Fig. 4a) . HA-positive ABCs were Pax5 hi and IRF4 lo , while HA-positive ASCs were Pax5 lo and IRF4 hi (Fig. 4b) .
The identity and specificity of HA-positive ASCs was confirmed by ex vivo ELISPOT, in which more than 90% of the IgG-secreting cells were specific to the the recombinant H1 HA protein ( Supplementary  Fig. 3a) . In contrast, no IgG-secreting cells were detected among sorted HA-positive ABCs (Supplementary Fig. 3a) , which confirmed that they had not differentiated into ASCs. However, after culturing HA-positive ABCs, we found that 62% of these cells secreted HA-binding antibodies (Supplementary Fig. 3b) .
At day 14, HA-positive ASCs were no longer detectable in blood (Fig. 4c) . In contrast, the frequency of HA-positive CD20 hi isotypeswitched B cells was highest at this time point (Fig. 4c) . Both HApositive ASCs and HA-positive ABCs had high expression of CD71 at day 7 (Fig. 4d) . The expression of CD71 and CD20 remained higher on HA-positive ABCs at day 14 than on naive B cells (Fig. 4d) . At 3 months after vaccination, CD71 expression on HA-positive MBCs was indistinguishable from that on naive B cells (Fig. 4d) . We next assessed the dynamics of HA-positive ABCs and HApositive ASCs following infection with influenza virus. At 4 d after subject enrollment, HA-positive ASCs (CD20 − ) and HA-positive ABCs (CD20 hi ) were identified among isotype-switched B cells (Fig. 4e) . These data demonstrated that HA-positive ABCs and ASCs were distinguished in the peripheral blood of humans shortly after vaccination against or infection with influenza virus.
HA-specific clones span ABCs and ASCs
We next sought to determine the clonal relationships among the ABC and ASC populations isolated after vaccination against influenza virus. We sequenced the IGH gene rearrangements in HA-positive and HA-negative ABCs at days 7 and 14 and from ASCs isolated at day 7 (peak of ASC response) from three donors following immunization with the 2014-2015 seasonal TIV (Supplementary Fig. 4) . Approximately 80-90% of IgG-secreting ASCs from day 7 were specific to TIV, as assessed by ELISPOT (Fig. 1c) ; therefore, we considered IgG lineages from the ASC pool to be representative of the vaccine-induced clonal lineages in subsequent analyses. B cell clonal lineages were defined by single-linkage clustering of complementarydetermining region 3 (CDR3) nucleotide sequences at a 90% identity threshold, for IGH rearrangements that shared use of variable and joining gene segments (called 'IGHV' and 'IGHJ' , respectively, here) and encoded a CDR3 of equal length.
An average of 33% (range, 20.1-41%) of the day-7 HA-positive ABC clonal lineages were also present among day-7 IgG + ASCs, while 20% (range, 10.4-26.7%) of the day-14 HA-positive ABC clonal lineages were detected among day-7 IgG + ASC clonal lineages (Fig. 5a, top) . H1-HA-positive ABCs represent only a fraction of the total response to all the different antigens derived from the three strains of influenza virus (H1N1, H3N2 and influenza B virus) included in seasonal TIV preparations. Therefore, we also assessed the clonal overlap between total (HA-positive and HA-negative) ABCs and IgG + ASCs. Among total ABC clonal lineages, we found that 34.4% (range, 21.8-52.6%) of day-7 ABCs and 24% (range, 16-29.1%) of day-14 ABCs were present among the day-7 IgG + ASCs (Fig. 5a, bottom) . These data showed that many of the B cell clones had members in both of these two distinct phenotypic subsets, but the majority of clones were present in only one subset. 
npg r e s o u r c e
We next assessed the frequency of each of the clonal lineages within the ABC and ASC pools. The clone frequencies within each pool were positively correlated (Fig. 5b) , which suggested that the extent of clonal expansion in each compartment was similar. The accumulation of SHMs in the IGH rearrangement provides information about the cell-division history within a clonal lineage. The average frequency of SHM of IGHV in responding ASCs and ABCs was 7% and 6.5%, respectively (Fig. 5c) . We then assessed SHM frequency in the clonal lineages shared by the ABC and ASC pools and found that the frequencies showed striking correlation between the two compartments (Fig. 5c) . Collectively, these SHM data suggested that at least a subset of the vaccine-induced ABC and ASC clonal lineages could have originated from the same MBCs and later diverged into distinct fates.
Clonal relationship of HA-specific ABCs to MBCs
To investigate the origin and fate of ABCs, we tracked ABC clonal lineages in two separate cohorts for 3 months following vaccination with TIV (Supplementary Fig. 5 ). For the first cohort, we sorted total ABCs and ASCs from three donors 7 d after immunization with the 2013-2014 TIV. We also sorted HA-positive ABCs from day 14 (the peak of ABC population expansion). To gather mutational data from additional members of the B cell clones, we analyzed the IGH repertoire in total PBMCs from day 0 (before vaccination) and days 28 and 90 after vaccination. We tracked HA-positive clonal lineages (sorted at day 14) at various time points. A relatively small fraction (average, 1%; range, 0.34-2%) of the day-14 HA-positive ABC lineages was detectable before vaccination (Supplementary Fig. 6 ). This frequency increased at 1 week after vaccination; an average of 11.6% (range, 4.4-23.3%) of the day-14 HA-positive ABC lineages were detectable among day-7 ABC lineages (Supplementary Fig. 6 ). 10% and 8.8% of day-14 HA-positive ABC clonal lineages persisted in peripheral blood at days 28 and 90 after vaccination, respectively (Supplementary Fig. 6 ), which suggested that these clones had become part of the resting MBC population.
To further explore the kinetics of and clonal relationship between ABCs and resting MBCs in humans after vaccination against influenza virus, we analyzed the corresponding repertoires of three additional donors during the 2014-2015 influenza season. HA-positive ABCs were sorted from days 7 and 14, as were MBCs from day 0 and days 14, 28 and 90 after vaccination ( Fig. 6a and Supplementary  Fig. 5b ). HA-positive clonal lineages present in the ABC populations persisted as resting MBCs, with an average of 36.25% (range, 12-55.6%) of day-7 HA-positive ABC lineages and an average of 26.7% (range, 21.5-36.0%) of day-14 HA-positive ABC lineages detected at day 90 after vaccination (Fig. 6) . We assessed the persistence of total ABC-derived lineages from day 7 and day 14 and found that a similar proportion of both total ABC lineages and HA-positive ABC lineages Fig. 6) . Both ASC lineages and ABC lineages were detected among MBCs obtained before vaccination: an average of 11.7% (range, 4.6-19.2%) of IgG + ASC lineages and 8% (range, 2.1-12.1%) of day-14 ABC lineages were detected in the memory pool before vaccination (Fig. 6) .
Notably, the ABC and ASC clonal lineages were largely distinct from resting MBCs sorted at day 14 (Fig. 6b) . The frequency of total ABC lineages that included day-14 resting MBCs ranged from 0.3% (donors 4 and 8) to 3.2% (donor 6) (Fig. 6b) . The frequency of HA-positive lineages in the day-14 resting MBC pool was very low and ranged from 0.4% (donor 4) to 4.7% (donor 6) (Fig. 6b) . These data therefore indicated that the ABC clones showed enrichment for vaccine-induced lineages and that few members of these clonal lineages remained in a non-activated state in the blood at day 14 after Time (d)   90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28   90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28   90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28  90  0  7  14  28 Time ( npg r e s o u r c e vaccination. Together our data showed that ABC clonal lineages contributed to the resting MBC population.
Minimal effect on SHM frequency by seasonal TIV vaccination
We next sought to investigate how the extent of SHM of HA-positive ABCs changed over time after vaccination with the seasonal TIV. To address this question, we longitudinally tracked HA-positive ABC clonal lineages and then compared the SHM frequency of IGHV segments at various time points before and after vaccination. HApositive ABCs underwent substantial population expansion from day 0 to day 7 and reached their peak abundance at day 14 after vaccination ( Fig. 7a) . Among the six donors we analyzed, we did not detect any substantial difference in the frequency of IGHV SHM before vaccination, early after vaccination (days 7 and 14) or at day 90 ( Fig. 7b and Supplementary Fig. 7a ). This result was consistent with the SHM frequency of individual HA-positive ABC clonal lineages from donors 4 and 6 (Fig. 7c,d ) and from donors 157, 162, 163 and 8 ( Supplementary  Fig. 7b ) at various time points before and after vaccination. The initial SHM frequency of individual HA-positive ABC clonal lineages did not seem to have an effect on whether the descendants of that particular lineage gained more mutations at later time points after vaccination. For example, all five HA-positive ABC clonal lineages from donor 4, tracked from baseline to day 90 after vaccination, did not show any substantial increase in SHM frequency despite the differences in their starting frequencies (Fig. 7c) . Longitudinal tracking of HAspecific ABC clones revealed no systematic gain in SHM following immunization against seasonal influenza virus ( Fig. 7b-d) .
DISCUSSION
MBCs and long-lived plasma cells provide a remarkably stable humoral immune memory that can last for a lifetime 22, 23 . Appropriate induction of both cell populations is therefore essential for optimal efficacy of prophylactic vaccines. Plasmablasts or ASCs in the peripheral blood of humans following infection and vaccination have been extensively characterized 9 . In the current study we defined an antigenspecific human activated B cell subset (ABCs) that was phenotypically, transcriptionally and functionally distinct from ASCs. ABCs were detected in adults within 7 d of vaccination against influenza virus and shortly after infection with influenza or Ebola virus. High-throughput sequencing of the repertoire of immunoglobulin-encoding genes in ABCs allowed us to track ABC clonal lineages and revealed that these lineages persisted in peripheral blood up to 90 d after vaccination (the latest time point assessed in these experiments), which suggested that the ABCs contributed to the MBC pool. Like ASCs, ABCs could be used for unbiased investigation of the antigen-specific B cell repertoire following infection and vaccination of humans and could also be used as a source of therapeutic monoclonal antibodies. Such ABC-derived monoclonal antibodies might differ from those derived from ASCs, in terms of quality and specificity 24 . 20-30% of the ABC clonal lineages were shared with the ASC compartment, which indicated that while some clones adopted both phenotypes, it might be more common for individual clones to be polarized to an ASC or ABC phenotype in a vaccine response. The frequency of ABC-ASC clonal lineage sharing could have been underestimated in our data due to the limited number of individual B cell members of antigen-specific clones captured in the volume of blood sampled. Published studies of vaccination against and infection with influenza virus have reported that antigen-specific IgGsecreting cells with a high frequency of IGH SHM dominate the ASC response, and have attributed this result to the probable MBC origin of these ASCs 4, 6, 17 . Here we found that HA-positive ABC lineages had SHM frequencies similar to those of the MBC pool before vaccination and ASCs after vaccination, which suggested that the ABCs were also derived from MBCs. This conclusion was further supported by tracking of members of the HA-positive lineage in the MBC compartment before vaccination into the ABC, ASC and MBC populations after vaccination.
MBCs, by definition, are quiescent 25 . This is a key distinction between the Ki67 + and CD71 hi ABC subset and resting MBCs. Our observation that very few ABC clonal lineages were detectable in the resting MBC compartment isolated at day 14 after vaccination supported the conclusion that vaccine-responsive clonal lineages in the MBC pool adopted an ABC phenotype after vaccination. In contrast, at days 28 and 90 after vaccination (after the immune response had subsided), we detected up to 60% of the ABC clonal lineages in the resting MBC compartment. The delayed kinetics of ABCs was consistent with published reports demonstrating delayed peaking of antigen-specific MBCs relative to that of ASCs following immunization against tetanus or influenza virus 6, 26 . Such a difference in timing following infection or vaccination might reflect a 'preference' for the immune system to first rapidly generate ASCs whose antibodies directly engage the foreign antigens. ABCs might have greater capacity to mutate their BCRs, as indicated by their higher expression of the cytidine deaminase AID relative to that of ASCs (data not shown); however, we did not detect substantial differences between these two subsets in their mutational load. Overall, our data support a model in which antigenic stimulation drives naive or resting MBCs to undergo a rapid clonal expansion; some of the resultant cells terminally differentiate into ASCs, and the rest of the progeny (ABCs) are released into the circulation more slowly. Over time, ABCs downregulate the activation markers and join the resting MBC pool.
Perhaps the most intriguing finding of our study was that the majority of responding B cell clones did not experience a substantial increase in SHM frequency over time following immunization with TIV. One possible explanation is that the TIV-induced B cells might have originated from pre-existing MBCs with receptors already of high affinity. Our cohorts were all adults with probable existing MBCs elicited by prior exposure to influenza-virus antigens, such as the HA of the 2009 pandemic H1 influenza virus included in the vaccine against seasonal influenza virus used in our study. Perhaps the lack of engagement of novel epitopes by responding B cells contributed to the minimal changes observed in SHM frequency. Alternatively, the amount of vaccine antigen might have been too limited to support a persistent germinalcenter reaction from which more highly mutated clones could have emerged. Finally, we note that the TIV used was not combined with an adjuvant. Future studies should investigate whether adjuvants change the dynamics of affinity maturation associated with vaccination against seasonal influenza virus in humans. Defining and studying ABCs along with ASCs in humans should reveal the intrinsic differences between the cells that constitute these two compartments and enhance understanding of the longevity of vaccine-induced B cell responses.
METHODS
Methods and any associated references are available in the online version of the paper. constant region sequence upstream of the primer used for amplification. For each donor, the clonal lineages were inferred from IGH rearrangements across the available samples by single linkage clustering of the CDR3 nucleotide sequences with a 90% identity threshold for IGH sequences that shared IGHV and IGHJ gene assignment (ignoring IGHV or IGHJ allele) and CDR3 length. HA-binding lineages were defined as clonal lineages for which a member in any phenotypic B cell subset was shown to bind HA in flow cytometry experiments; for lineages that had members detected in both HA-positive and HA-negative populations from flow sorting, we considered the lineage to be HA-binding if at least ten reads were detected in the HA-positive samples, and at least 10% of total reads from the lineage in sorted cells were found in the HA-positive populations. IgG-expressing ASC lineages were defined as those containing members expressing IgG subtypes IgG1, IgG2 or IgG3. IGHV mutation percentages were calculated for the region spanning FR1 through the end of FR3. In summarizing IGHV mutation frequencies in B cell subsets, the mean mutation frequency was calculated for each B cell clone, then the median of these means over all clones was determined. The distribution of clonal lineage members across the different sample points was visualized using Circos 32 .
Statistics. Statistical analyses (described in context) were performed using GraphPad Prism and R.
